Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

McKesson net disappoints Wall Street

Article Abstract:

McKesson HBOC Inc. posted lower-than-expected earnings for the first-quarter of 1999. The company cautioned that the 1999 year would be a period of transition following its merger with HBO & Co. McKesson posted approximately $14 million (13.07 milion euros) in distribution operating margins for the period. The company posted 30 cents per share in income before items. Analysts predicted 34 cents per share.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
United States, Drugs and Druggists' Sundries Wholesalers, Drugs, Cosmetics, Toiletries Whsle, Finance, Wholesale industry, Wholesale trade, Health products industry, Health care products industry, McKesson Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


U.K. drug companies expect strong results for 3rd quarter

Article Abstract:

GlaxoSmithKline PLC and AstraZeneca PLC are forecasting strong figures for the 2001 third-quarter. Both companies are the two largest pharmaceutical firms in the United Kingdom.

Author: Rodgers, Susannah
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
United Kingdom, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Pharmaceutical industry, Forecasts and trends, AstraZeneca PLC, AZN, GlaxoSmithKline PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: BHP Billiton's net just meets expectations. BHP swung to a profit in third quarter. Rio Tinto's net rose 18% last year to $1.51 billion
  • Abstracts: InVision holder sees windfall. GE's bid for Finnish company faces tough regulator at EU
  • Abstracts: Mutual-fund firm tries to shake dismal overseas returns. Funds expect tough year
  • Abstracts: Sulzer Medica shares soar on U.S. settlement. Sulzer Medica reported loss for first quarter. Nokia says sales to hit low end of its projections
  • Abstracts: ICN's U.S. suit hits Yugoslav, Serb leaders. Amgen plans to buy Immunex for $16 billion in cash, stock. Bristol-Myers nears pact to buy ImClone stake
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.